南大蘇富特(08045.HK)配售新H股的中國證監會批准失效
格隆匯1月6日丨南大蘇富特(08045.HK)公吿,於本公佈日期,由於COVID-19疫情持續導致資本市場狀況整體下行,且需要額外時間完成相關手續,故未能按配售協議向不少於六名承配人配售配售股份。因此,誠如通函所披露,由2020年12月29日起至2021年1月6日期間有效的特別授權將於緊隨2021年1月6日後失效。此外,公司於2020年初取得的中國證監會批准將於緊隨2021年1月6日後失效。
根據配售協議條款,倘條件於配售截止日期下午五時正前並未達成,配售協議將自動終止。儘管如此,於本公佈日期,配售協議於配售截止日期屆滿前並不被視為已終止。倘其後有任何董事會視為可行及合適以完成配售事項的計劃,公司將須重新召開董事會會議、股東特別大會及類別股東大會,以就配發及發行配售股份取得新的特別授權,及除滿足上述其他條件外,根據相關中國法律及法規取得新的中國證監會批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.